CD8A and lung carcinoma: It is worth noting that vaccination produced by the lung cancer cell line KP-LC derived from iPS cells or the lung cancer cell line KPL 160302S derived from early lung cancer models can both significantly prolong the survival of lung cancer mice, and their effect on CD8+ T cells and CD4+ T cells infiltration are similar.